Nanocapsules of oxalate oxidase for hyperoxaluria treatment

Ming Zhao, Duo Xu, Di Wu, James Whittaker, Robert Terkeltaub, Yunfeng Lu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Enzyme therapeutics have great potential for the treatment of systemic disorders such as urolithiasis and nephrocalcinosis, which are caused by the excessive accumulation of oxalate. However, exogenous enzymes have short half-lives in vivo and elicit high immunogenicity, which largely limit the therapeutic outcomes. Herein, we report a delivery strategy whereby therapeutic enzymes are encapsulated within a thin zwitterionic polymer shell to form enzyme nanocapsules. The strategy is exemplified by the encapsulation of oxalate oxidase (OxO) for the treatment of hyperoxaluria, because as-synthesized OxO nanocapsules have a prolonged blood circulation half-life and elicit reduced immunogenicity. Our design of enzyme nanocapsules that enable the systemic delivery of therapeutic enzymes can be extended to various biomedical applications. [Figure not available: see fulltext.]

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalNano Research
DOIs
StateAccepted/In press - Nov 27 2017

Fingerprint

oxalate oxidase
Nanocapsules
Enzymes
Oxalates
Hemodynamics
Encapsulation
Oxidoreductases
Polymers

Keywords

  • enzyme therapeutics
  • hyperoxaluria
  • long circulation
  • nanomedicine
  • oxalate oxidase
  • protein delivery

ASJC Scopus subject areas

  • Materials Science(all)
  • Electrical and Electronic Engineering

Cite this

Zhao, M., Xu, D., Wu, D., Whittaker, J., Terkeltaub, R., & Lu, Y. (Accepted/In press). Nanocapsules of oxalate oxidase for hyperoxaluria treatment. Nano Research, 1-7. https://doi.org/10.1007/s12274-017-1898-3

Nanocapsules of oxalate oxidase for hyperoxaluria treatment. / Zhao, Ming; Xu, Duo; Wu, Di; Whittaker, James; Terkeltaub, Robert; Lu, Yunfeng.

In: Nano Research, 27.11.2017, p. 1-7.

Research output: Contribution to journalArticle

Zhao, M, Xu, D, Wu, D, Whittaker, J, Terkeltaub, R & Lu, Y 2017, 'Nanocapsules of oxalate oxidase for hyperoxaluria treatment', Nano Research, pp. 1-7. https://doi.org/10.1007/s12274-017-1898-3
Zhao, Ming ; Xu, Duo ; Wu, Di ; Whittaker, James ; Terkeltaub, Robert ; Lu, Yunfeng. / Nanocapsules of oxalate oxidase for hyperoxaluria treatment. In: Nano Research. 2017 ; pp. 1-7.
@article{c799168bbb6e4fa2bac584692c9feff3,
title = "Nanocapsules of oxalate oxidase for hyperoxaluria treatment",
abstract = "Enzyme therapeutics have great potential for the treatment of systemic disorders such as urolithiasis and nephrocalcinosis, which are caused by the excessive accumulation of oxalate. However, exogenous enzymes have short half-lives in vivo and elicit high immunogenicity, which largely limit the therapeutic outcomes. Herein, we report a delivery strategy whereby therapeutic enzymes are encapsulated within a thin zwitterionic polymer shell to form enzyme nanocapsules. The strategy is exemplified by the encapsulation of oxalate oxidase (OxO) for the treatment of hyperoxaluria, because as-synthesized OxO nanocapsules have a prolonged blood circulation half-life and elicit reduced immunogenicity. Our design of enzyme nanocapsules that enable the systemic delivery of therapeutic enzymes can be extended to various biomedical applications. [Figure not available: see fulltext.]",
keywords = "enzyme therapeutics, hyperoxaluria, long circulation, nanomedicine, oxalate oxidase, protein delivery",
author = "Ming Zhao and Duo Xu and Di Wu and James Whittaker and Robert Terkeltaub and Yunfeng Lu",
year = "2017",
month = "11",
day = "27",
doi = "10.1007/s12274-017-1898-3",
language = "English (US)",
pages = "1--7",
journal = "Nano Research",
issn = "1998-0124",
publisher = "Press of Tsinghua University",

}

TY - JOUR

T1 - Nanocapsules of oxalate oxidase for hyperoxaluria treatment

AU - Zhao, Ming

AU - Xu, Duo

AU - Wu, Di

AU - Whittaker, James

AU - Terkeltaub, Robert

AU - Lu, Yunfeng

PY - 2017/11/27

Y1 - 2017/11/27

N2 - Enzyme therapeutics have great potential for the treatment of systemic disorders such as urolithiasis and nephrocalcinosis, which are caused by the excessive accumulation of oxalate. However, exogenous enzymes have short half-lives in vivo and elicit high immunogenicity, which largely limit the therapeutic outcomes. Herein, we report a delivery strategy whereby therapeutic enzymes are encapsulated within a thin zwitterionic polymer shell to form enzyme nanocapsules. The strategy is exemplified by the encapsulation of oxalate oxidase (OxO) for the treatment of hyperoxaluria, because as-synthesized OxO nanocapsules have a prolonged blood circulation half-life and elicit reduced immunogenicity. Our design of enzyme nanocapsules that enable the systemic delivery of therapeutic enzymes can be extended to various biomedical applications. [Figure not available: see fulltext.]

AB - Enzyme therapeutics have great potential for the treatment of systemic disorders such as urolithiasis and nephrocalcinosis, which are caused by the excessive accumulation of oxalate. However, exogenous enzymes have short half-lives in vivo and elicit high immunogenicity, which largely limit the therapeutic outcomes. Herein, we report a delivery strategy whereby therapeutic enzymes are encapsulated within a thin zwitterionic polymer shell to form enzyme nanocapsules. The strategy is exemplified by the encapsulation of oxalate oxidase (OxO) for the treatment of hyperoxaluria, because as-synthesized OxO nanocapsules have a prolonged blood circulation half-life and elicit reduced immunogenicity. Our design of enzyme nanocapsules that enable the systemic delivery of therapeutic enzymes can be extended to various biomedical applications. [Figure not available: see fulltext.]

KW - enzyme therapeutics

KW - hyperoxaluria

KW - long circulation

KW - nanomedicine

KW - oxalate oxidase

KW - protein delivery

UR - http://www.scopus.com/inward/record.url?scp=85035132891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035132891&partnerID=8YFLogxK

U2 - 10.1007/s12274-017-1898-3

DO - 10.1007/s12274-017-1898-3

M3 - Article

AN - SCOPUS:85035132891

SP - 1

EP - 7

JO - Nano Research

JF - Nano Research

SN - 1998-0124

ER -